Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosa

Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0027723. doi: 10.1128/aac.00277-23. Epub 2023 May 11.

Abstract

Resistant Gram-negative bacteria are a growing concern in the United States, leading to significant morbidity and mortality. We identified a 72-year-old female patient who presented with unilateral vision loss. She was found to have a large corneal ulcer with hypopyon. Culture of corneal scrapings grew extensively drug-resistant Pseudomonas aeruginosa. Treatment involved a combination of systemic and topical antibiotics. Whole genome sequencing revealed the presence of blaVIM-80, blaGES-9, and other resistance determinants. This distinctive organism was linked to an over-the-counter artificial tears product.

Keywords: Pseudomonas aeruginosa; antibacterial agents; cefiderocol; corneal ulcer; imipenem; keratitis; lubricant eye drops; polymyxin B.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Corneal Ulcer* / drug therapy
  • Corneal Ulcer* / microbiology
  • Female
  • Gram-Negative Bacteria
  • Humans
  • Microbial Sensitivity Tests
  • Pseudomonas Infections* / microbiology
  • Pseudomonas aeruginosa / genetics

Substances

  • Anti-Bacterial Agents